Tetrahydrobiopterin Supplementation Protects Retinal Ganglion Cells Against NMDA-Induced Excitotoxicity Through nNOS-Coupled Nitric Oxide Signaling

Purpose: Excitotoxic injury triggered by excessive N-methyl-d-aspartate (NMDA) receptor activation represents an important mechanism underlying retinal neurodegeneration in glaucoma. Tetrahydrobiopterin (BH4), an essential cofactor for nitric oxide synthase (NOS), exhibits neuroprotective potential in multiple neurodegenerative diseases, but its role in retinal ganglion cells (RGCs) under excitotoxic injury remains unclear. This study assessed the neuroprotective effects of BH4 against excitotoxic retinal injury and explored its underlying mechanisms. Methods: Glutamate-treated R28 cells and intravitreal NMDA-injected rat retinas were used as in vitro and in vivo excitotoxic injury models, respectively. BH4 levels were measured after injury. Cell viability, oxidative stress, apoptosis, RGC survival, retinal morphology, visual function, and NOS activity were assessed following BH4 supplementation. Results: BH4 levels were significantly reduced in glutamate-injured R28 cells and NMDA-damaged retinas. BH4 supplementation improved cell survival, reduced oxidative stress, and attenuated apoptosis in injured R28 cells. In vivo, BH4 preserved RGC survival, alleviated retinal damage, and improved visual function after NMDA injury. Mechanistically, BH4 restored neuronal nitric oxide synthase (nNOS) coupling and activity, increased nitric oxide levels, re-established nitroso-redox homeostasis, and suppressed apoptotic signaling. Conclusions: BH4 deficiency contributes to glutamate-induced retinal neurodegeneration by promoting nNOS uncoupling and nitroso-redox imbalance. Restoring BH4 levels protects against excitotoxic RGC damage, suggesting the BH4-nNOS axis as a potential therapeutic target for retinal neurodegeneration.

Authors

Institutions

Publication Details

Journal
Investigative Ophthalmology & Visual Science
Published
2026-11-12
DOI
https://doi.org/10.1167/iovs.67.13.19
Primary Topic
Glaucoma and retinal disorders
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Tetrahydrobiopterin Supplementation Protects Retinal Ganglion Cells Against NMDA-Induced Excitotoxicity Through nNOS-Coupled Nitric Oxide Signaling

Weizhou Fang, Lemeng Feng, Zeyi Zhao, Shuhan Meng et al.
Investigative Ophthalmology & Visual Science
Glaucoma and retinal disorders
article

Tetrahydrobiopterin Supplementation Protects Retinal Ganglion Cells Against NMDA-Induced Excitotoxicity Through nNOS-Coupled Nitric Oxide Signaling

Weizhou Fang, Lemeng Feng, Zeyi Zhao, Shuhan Meng, Qing Dong, Lexi Ding, Chao Wang, Xiaobo Xia
article en

Abstract

Purpose: Excitotoxic injury triggered by excessive N-methyl-d-aspartate (NMDA) receptor activation represents an important mechanism underlying retinal neurodegeneration in glaucoma. Tetrahydrobiopterin (BH4), an essential cofactor for nitric oxide synthase (NOS), exhibits neuroprotective potential in multiple neurodegenerative diseases, but its role in retinal ganglion cells (RGCs) under excitotoxic injury remains unclear. This study assessed the neuroprotective effects of BH4 against excitotoxic retinal injury and explored its underlying mechanisms. Methods: Glutamate-treated R28 cells and intravitreal NMDA-injected rat retinas were used as in vitro and in vivo excitotoxic injury models, respectively. BH4 levels were measured after injury. Cell viability, oxidative stress, apoptosis, RGC survival, retinal morphology, visual function, and NOS activity were assessed following BH4 supplementation. Results: BH4 levels were significantly reduced in glutamate-injured R28 cells and NMDA-damaged retinas. BH4 supplementation improved cell survival, reduced oxidative stress, and attenuated apoptosis in injured R28 cells. In vivo, BH4 preserved RGC survival, alleviated retinal damage, and improved visual function after NMDA injury. Mechanistically, BH4 restored neuronal nitric oxide synthase (nNOS) coupling and activity, increased nitric oxide levels, re-established nitroso-redox homeostasis, and suppressed apoptotic signaling. Conclusions: BH4 deficiency contributes to glutamate-induced retinal neurodegeneration by promoting nNOS uncoupling and nitroso-redox imbalance. Restoring BH4 levels protects against excitotoxic RGC damage, suggesting the BH4-nNOS axis as a potential therapeutic target for retinal neurodegeneration.

Investigative Ophthalmology & Visual ScienceVol. 67(13)
Central South University (CN), Xiangya Hospital Central South University (CN)
Good health and well-being
Glaucoma and retinal disorders
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon